Analyst Ratings for Genmab A/S (GMAB)
GMAB Rating Summary
GMAB Price Target Summary
- Highest: $41.50 (Jefferies)
- Lowest: $30.50 (Goldman Sachs)
- Average: $36.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$36.50 (+44.4%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
Rating Score: 6.9 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/27/2026 | Truist Securities | Gregory Renza | New Coverage | Buy (N/A) |
40.00 (N/A) |
26.89 (25.27) |
-6.02% | Details |
| 4/22/2026 | Goldman Sachs | Rajan Sharma | Upgrade | Buy (Neutral) |
30.50 (24.50) |
27.91 (25.27) |
-9.46% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
